Visby Medical, Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $7.8M | 383 | 97.9% |
| Consulting Fee | $139,893 | 36 | 1.8% |
| Royalty or License | $20,000 | 2 | 0.3% |
| Food and Beverage | $4,490 | 81 | 0.1% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| A Prospective Study to Collect Samples for Reserach and Development of Visby Medical Products Relating to Respiratory Infections (Clinical Protocol No. TP-000312) | $1.0M | 0 | 40 |
| Clinical Evaluation of Visby Medical Personal PCR Women's Sexual Health Test for the Detection of Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), and Trichomonas vaginalis (TV) Using Self-Collected Vaginal Swabs | $884,785 | 0 | 54 |
| Clinical Evaluation of Visby Medical Personal PCR Womens Sexual Health Test for the Detection of Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), and Trichomonas vaginalis (TV) Using Self-Collected Vaginal Swabs | $776,577 | 0 | 54 |
| Clinical Evaluation of the Visby Medical Flu and COVID-19 Test for the Detection and Differentiation of SARS-CoV-2, Influenza A, and Influenza B Viral RNA | $772,295 | 0 | 60 |
| A Prospective Study to Collect Samples for Reserach and Development of Visby Medical Products Relating to Respiratory Infections/Clinical Evaluation of the Visby Medical Respiratory Health Test for the Detection and Differentiation of SARS-CoV-2, Influenza A and Influenza B Viral RNA/Clinical Evaluation of Visby Medical Personal PCR Womens Sexual Health Test for the Detection of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis using self-collected vaginal swabs | $602,915 | 0 | 12 |
| Clinical Evaluation of the Visby Medical Respiratory Health Test for the Detection and Differentiation of SARS-CoV-2, Influenza A and Influenza B Viral RNA | $516,289 | 0 | 12 |
| A Prospective Study to Collect Samples for Reserach and Development of Visby Medical Products Relating to Respiratory Infections | $384,621 | 0 | 11 |
| Clinical Evaluation of Visby Medical Personal PCR Womens Sexual Health Test for the Detection of Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), and Trichomonas vaginalis (TV) using self-collected vaginal swabs | $375,811 | 0 | 18 |
| Clinical Evaluation of Visby Medical Personal PCR Women's Sexual Health Test for the Detection of Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), and Trichomonas vaginalis (TV) Using Self-Collected Vaginal Swabs / A Prospective Collection of Vaginal Swab Samples from Subjects with Suspected Sexually Transmitted Infections for Verification and Validation Studies of the Visby Medical Sexual Health Test | $357,834 | 0 | 13 |
| Clinical Evaluation of the Visby COVID-19 Test for the Detection of Viral RNA from the SARS-CoV-2 Virus (Clinical Protocol TP-000362) | $320,158 | 0 | 5 |
| A Prospective Collection of Vaginal Swab Samples from Subjects with Suspected Sexually Transmitted Infections for Verification and Validation Studies of the Visby Medical Sexual Health Test / A Beta Study of the Visby Sexual Health Test / Clinical Evaluation of the Visby COVID-19 Test for the Detection of Viral RNA from the SARS-CoV-2 Virus / A Prospective Study to Collect Samples for Reserach and Development of Visby Medical Products Relating to Respiratory Infections | $276,511 | 0 | 11 |
| TP-000612 Reproducibility/Near-cutoff Study of the Visby Medical Respiratory Health Test | $248,192 | 0 | 10 |
| TP-000669 Clinical Evaluation of Visby Medical Personal PCR Womens Sexual Health Test for the Detection of Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), and Trichomonas vaginalis (TV) using self-collected vaginal swabs | $160,825 | 0 | 4 |
| A Follow-up Reproducibility/Near-cutoff Study of the Click Sexual Health Test CT/NG/TV (Clinical Protocol No. TP-000377) / A Beta Study of the Visby Sexual Health Test (Clinical Protocol No. TP-000516) / Reproducibility/Near-cutoff Study of the Visby Medical Sexual Health Test (Clinical Protocol No. TP-000558) | $153,059 | 0 | 4 |
| TP-000547 Clinical Evaluation of the Visby Medical Respiratory Health Test for the Detection and Differentiation of SARS-CoV-2, Influenza A and Influenza B Viral RNA | $137,401 | 0 | 5 |
| A Follow-up Reproducibility/Near-cutoff Study of the Click Sexual Health Test CT/NG/TV / A Beta Study of the Visby Sexual Health Test / Reproducibility/Near-cutoff Study of the Visby Medical Sexual Health Test | $129,930 | 0 | 4 |
| Reproducibility/Near-cutoff Study of the Visby Medical Respiratory Health Test | $117,712 | 0 | 5 |
| A Prospective Collection of Vaginal Swab Samples from Subjects with Suspected Sexually Transmitted Infections for Verification and Validation Studies of the Visby Medical Sexual Health Test (Clinical Protocol No. TP-000033) / A Beta Study of the Visby Sexual Health Test (Clinical Protocol No. TP-000516) | $117,377 | 0 | 10 |
| A Prospective Collection of Vaginal Swab Samples from Subjects with Suspected Sexually Transmitted Infections for Verification and Validation Studies of the Visby Medical Sexual Health Test. A Follow-up Reproducibility/Near-cutoff Study of the Click Sexual Health Test CT/NG/TV. Reproducibility/Near-cutoff Study of the Visby Medical Sexual Health Test. A Prospective Study to Collect Samples for Reserach and Development of Visby Medical Products Relating to Respiratory Infections | $114,683 | 0 | 9 |
| Clinical Evaluation of the Visby Medical Respiratory Health Test for the Detection and Differentiation of SARS-CoV-2, Influenza A and Influenza B Viral RNA / A Prospective Study to Collect Samples for Reserach and Development of Visby Medical Products Relating to Respiratory Infections | $81,497 | 0 | 1 |
| A Prospective Study to Collect Samples for Reserach and Development of Visby Medical Products Relating to Respiratory Infections (Clinical Protocol No. TP-000312) /TP-000547 Clinical Evaluation of the Visby Medical Respiratory Health Test for the Detection and Differentiation of SARS-CoV-2, Influenza A and Influenza B Viral RNA | $53,816 | 0 | 1 |
| A Follow-up Reproducibility/Near-cutoff Study of the Click Sexual Health Test CT/NG/TV (Clinical Protocol No. TP-000377) / Reproducibility/Near-cutoff Study of the Visby Medical Sexual Health Test (Clinical Protocol No. TP-000558) | $48,264 | 0 | 2 |
| Clinical Evaluation of the Visby COVID-19 Test Version B for the Detection of Viral RNA from the SARS-CoV-2 Virus (Clinical Protocol TP-000413) | $33,258 | 0 | 2 |
| Clinical Evaluation of Visby Medical Personal PCR Womens Sexual Health Test for the Detection of Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), and Trichomonas vaginalis (TV) using self-collected vaginal swabs (Clinical Protocol TP-000669) | $33,116 | 0 | 5 |
| Pre-Clinical Evaluation of Visby Medical Mens Sexual Health Test | $31,967 | 0 | 2 |
| TP-000700 Pre-Clinical Evaluation of Visby Medical Mens Sexual Health Test | $18,988 | 0 | 1 |
| A Prospective Collection of Vaginal Swab Samples from Subjects with Suspected Sexually Transmitted Infections for Verification and Validation Studies of the Visby Medical Sexual Health Test (Clinical Protocol No. TP-000033) | $16,935 | 0 | 6 |
| Clinical Evaluation of Visby Medical Personal PCR Women's Sexual Health Test for the Detection of Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), and Trichomonas vaginalis (TV) using self-collected vaginal swabs | $13,500 | 0 | 1 |
| A Prospective Study to Collect Samples for Research and Development of Visby Medical Products Relating to Respiratory Infections (TP-000312) | $10,500 | 0 | 2 |
| Clinical Evaluation of the Visby Medical Respiratory Health Test for the Detection and Differentiation of SARS-CoV-2, Influenza A and Influenza B Viral RNA / Clinical Evaluation of Visby Medical Personal PCR Women's Sexual Health Test for the Detection of Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), and Trichomonas vaginalis (TV) Using Self-Collected Vaginal Swabs | $4,488 | 0 | 5 |
Payments by Medical Specialty
| Specialty | Total Paid | Doctors | Avg/Doctor |
|---|---|---|---|
| Infectious Disease | $50,838 | 5 | $10,168 |
| Emergency Medicine | $45,346 | 8 | $5,668 |
| Pediatric Infectious Diseases | $20,000 | 1 | $20,000 |
| Family Medicine | $10,616 | 7 | $1,517 |
| Obstetrics & Gynecology | $10,297 | 22 | $468.05 |
| Internal Medicine | $6,064 | 4 | $1,516 |
| Family | $249.32 | 9 | $27.70 |
| Nurse Practitioner | $238.59 | 3 | $79.53 |
| General Practice | $237.64 | 1 | $237.64 |
| Physician Assistant | $139.89 | 3 | $46.63 |
| Pulmonary Disease | $115.40 | 1 | $115.40 |
| Pediatrics | $53.56 | 2 | $26.78 |
| Gynecology | $42.20 | 2 | $21.10 |
| Nutrition, Pediatric | $28.31 | 1 | $28.31 |
| Advanced Practice Midwife | $18.42 | 1 | $18.42 |
| Midwife | $18.42 | 1 | $18.42 |
| Obstetrics | $18.42 | 1 | $18.42 |
| Medical | $17.67 | 1 | $17.67 |
| Addiction Medicine | $17.39 | 1 | $17.39 |
| Women's Health | $17.22 | 1 | $17.22 |
| Hospice and Palliative Medicine | $9.07 | 1 | $9.07 |
| Clinical Pathology/Laboratory Medicine | $0 | 1 | $0 |
| Dermatology | $0 | 1 | $0 |
| Endocrinology, Diabetes & Metabolism | $0 | 1 | $0 |
Top Paid Doctors — Page 2
| Doctor | Specialty | Location | Total | 2022 |
|---|---|---|---|---|
| Dr. Kumar Alagappan, Md, MD | Emergency Medicine | Houston, TX | $114.12 | $0 |
| Kyla Howrish, Fnp-C, FNP-C | Family | Magnolia, TX | $100.00 | $0 |
| Amanda Joy, Pa-C, PA-C | Physician Assistant | Belcamp, MD | $100.00 | $0 |
| Bernice Sessa, Md, MD | Emergency Medicine | Ann Arbor, MI | $100.00 | $0 |
| Dr. Erica Hwang, M.d, M.D | Internal Medicine | Bethesda, MD | $52.40 | $0 |
| Ayobami Olufadeji, M.d, M.D | Emergency Medicine | Boston, MA | $39.12 | $0 |
| Elizabeth Orwick, M.d, M.D | Obstetrics & Gynecology | Columbus, OH | $38.80 | $0 |
| Donna Diaz, M.d, M.D | Obstetrics & Gynecology | Columbus, OH | $38.80 | $0 |
| Todd Jenkins, M.d, M.D | Obstetrics & Gynecology | Columbus, OH | $38.80 | $0 |
| Dr. Jennifer Fraik, Fnp-C, FNP-C | Family | Bemidji, MN | $28.33 | $0 |
| Lydie Hazan, Md, MD | Nutrition, Pediatric | Beverly Hills, CA | $28.31 | $0 |
| Priyadarsini Ramesh, M.d, M.D | Pediatrics | Buffalo Grove, IL | $26.78 | $0 |
| Carla Duban, Md, MD | Pediatrics | Saint Louis, MO | $26.78 | $0 |
| Nicole Williams, Md, MD | Gynecology | Chicago, IL | $26.54 | $0 |
| Ms. April Dewhite, M.d, M.D | Obstetrics & Gynecology | Chicago, IL | $26.54 | $0 |
| Dr. Rachel Lev, Aprn, Whnp-Bc, APRN, WHNP-BC | Nurse Practitioner | Chicago, IL | $26.54 | $0 |
| David Herbert, M.d, M.D | Emergency Medicine | San Angelo, TX | $25.66 | $0 |
| Oksana Trotska, Np-C, NP-C | Family | Troy, MI | $22.22 | $0 |
| Nadezhda Krasik, Pa, PA | Physician Assistant | Troy, MI | $22.22 | $0 |
| Glenda Embry, Cnm, CNM | Advanced Practice Midwife | Elgin, IL | $18.42 | $0 |
| Dr. Michael Riermaier, M.d, M.D | Obstetrics | Elgin, IL | $18.42 | $0 |
| Diane Smith | Midwife | Elgin, IL | $18.42 | $0 |
| Ms. Paige Anderson, Pa-C, PA-C | Medical | San Leandro, CA | $17.67 | $0 |
| Alexander Stempel | Physician Assistant | Madera, CA | $17.67 | $0 |
| Max Pollock, Np-C, NP-C | Family | San Francisco, CA | $17.67 | $0 |
Top Products
- Visby Medical Sexual Health Click Test $4.2M
- Visby Medical Respiratory Health Test $3.0M
Associated Products (4)
Payment Categories
- Food & Beverage $4,490
- Consulting $139,893
- Research $7.8M
- Royalties $20,000
About Visby Medical, Inc.
Visby Medical, Inc. has made $8.0M in payments to 79 healthcare providers, recorded across 502 transactions in the CMS Open Payments database. In 2024, the company paid $2.6M. The top product by payment volume is Visby Medical Sexual Health Click Test ($4.2M).
Payments were distributed across 24 medical specialties. The top specialty by payment amount is Infectious Disease ($50,838 to 5 doctors).
Payment categories include: Food & Beverage ($4,490), Consulting ($139,893), Research ($7.8M), Royalties ($20,000).
Visby Medical, Inc. is associated with 4 products in the CMS Open Payments database, including Visby Medical Sexual Health Click Test, Visby Medical Respiratory Health Test, and Visby Medical COVID-19 Test.